 |
 |
|
|
|
| Bivalirudin Acetate |
 |
| medcine and healthy production |
 |
| 128270-60-0 |
 |
1 Appearance White powder White powder
2 Identity 2180.29¡¾1.0 2180.7
3 Specific Optical Rotation (c=0.5,1%HAc) -100¢¦-120.0¡Æ -115¡Æ
4 Amino Acid Composition ¡¾ 10% Conforms
5 Peptide Purity (By HPLC) ¡Ã98% by area integration 98.8%
6 Related Substance (By HPLC) Total Impurities (%)¡Â2.0% Largest Single Impurity (%)¡Â 1.0% 1.2% 0.5%
7 Acetate Content (By HPLC) ¡Â15% 11.2%
8 Water Content (Karl Fischer) ¡Â6.0% 4.8%
9 Bacterial Endotoxins ¡Â15 EU/mg Conforms
10 Peptide Content (N determination) ¡Ã80% 83.6%
|
 |
USP31/EP
|
 |
1 Appearance White powder White powder
2 Identity 2180.29¡¾1.0 2180.7
3 Specific Optical Rotation (c=0.5,1%HAc) -100¢¦-120.0¡Æ -115¡Æ
4 Amino Acid Composition ¡¾ 10% Conforms
5 Peptide Purity (By HPLC) ¡Ã98% by area integration 98.8%
6 Related Substance (By HPLC) Total Impurities (%)¡Â2.0% Largest Single Impurity (%)¡Â 1.0% 1.2% 0.5%
7 Acetate Content (By HPLC) ¡Â15% 11.2%
8 Water Content (Karl Fischer) ¡Â6.0% 4.8%
9 Bacterial Endotoxins ¡Â15 EU/mg Conforms
10 Peptide Content (N determination) ¡Ã80% 83.6%
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
